143 related articles for article (PubMed ID: 29597097)
1. Performance evaluation of four type-specific commercial assays for detection of herpes simplex virus type 1 antibodies in a Middle East and North Africa population.
Aldisi RS; Elsidiq MS; Dargham SR; Sahara AS; Al-Absi ES; Nofal MY; Mohammed LI; Abu-Raddad LJ; Nasrallah GK
J Clin Virol; 2018 Jun; 103():1-7. PubMed ID: 29597097
[TBL] [Abstract][Full Text] [Related]
2. Performance of four diagnostic assays for detecting herpes simplex virus type 2 antibodies in the Middle East and North Africa.
Nasrallah GK; Dargham SR; Sahara AS; Elsidiq MS; Abu-Raddad LJ
J Clin Virol; 2019 Feb; 111():33-38. PubMed ID: 30639845
[TBL] [Abstract][Full Text] [Related]
3. Estimating seroprevalence of herpes simplex virus type 1 among different Middle East and North African male populations residing in Qatar.
Nasrallah GK; Dargham SR; Mohammed LI; Abu-Raddad LJ
J Med Virol; 2018 Jan; 90(1):184-190. PubMed ID: 28817197
[TBL] [Abstract][Full Text] [Related]
4. Herpes Simplex Virus Type 2 Seroprevalence Among Different National Populations of Middle East and North African Men.
Dargham SR; Nasrallah GK; Al-Absi ES; Mohammed LI; Al-Disi RS; Nofal MY; Abu-Raddad LJ
Sex Transm Dis; 2018 Jul; 45(7):482-487. PubMed ID: 29465656
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing.
Smith JS; Bailey RC; Westreich DJ; Maclean I; Agot K; Ndinya-Achola JO; Hogrefe W; Morrow RA; Moses S
Sex Transm Infect; 2009 Apr; 85(2):92-6. PubMed ID: 18955387
[TBL] [Abstract][Full Text] [Related]
6. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations.
Ashley-Morrow R; Nollkamper J; Robinson NJ; Bishop N; Smith J
Clin Microbiol Infect; 2004 Jun; 10(6):530-6. PubMed ID: 15191381
[TBL] [Abstract][Full Text] [Related]
7. Comparison of commercial methods of immunoblot, ELISA, and chemiluminescent immunoassay for detecting type-specific herpes simplex viruses-1 and -2 IgG.
de Ory F; Guisasola ME; Balfagón P; Sanz JC
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28332725
[TBL] [Abstract][Full Text] [Related]
8. Performance of Commercial Enzyme-Linked Immunoassays for Diagnosis of Herpes Simplex Virus-1 and Herpes Simplex Virus-2 Infection in a Clinical Setting.
Agyemang E; Le QA; Warren T; Magaret AS; Selke S; Johnston C; Jerome KR; Wald A
Sex Transm Dis; 2017 Dec; 44(12):763-767. PubMed ID: 28876290
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of commercial herpes simplex virus IgG and IgM enzyme immunoassays.
Liermann K; Schäfler A; Henke A; Sauerbrei A
J Virol Methods; 2014 Apr; 199():29-34. PubMed ID: 24418499
[TBL] [Abstract][Full Text] [Related]
10. Novel recombinant ELISA assays for determination of type-specific IgG antibodies against HSV-1 and HSV-2.
Sauerbrei A; Wutzler P
J Virol Methods; 2007 Sep; 144(1-2):138-42. PubMed ID: 17548119
[TBL] [Abstract][Full Text] [Related]
11. Novel approach for specific detection of herpes simplex virus type 1 and 2 antibodies and immunoglobulin G and M antibodies.
Ohana B; Lipson M; Vered N; Srugo I; Ahdut M; Morag A
Clin Diagn Lab Immunol; 2000 Nov; 7(6):904-8. PubMed ID: 11063496
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Euroimmun Anti-Zika Virus IgM and IgG Enzyme-Linked Immunosorbent Assays for Zika Virus Serologic Testing.
L'Huillier AG; Hamid-Allie A; Kristjanson E; Papageorgiou L; Hung S; Wong CF; Stein DR; Olsha R; Goneau LW; Dimitrova K; Drebot M; Safronetz D; Gubbay JB
J Clin Microbiol; 2017 Aug; 55(8):2462-2471. PubMed ID: 28566316
[TBL] [Abstract][Full Text] [Related]
13. Comparative performance of a novel herpes simplex virus type 2-specific enzyme-linked immunosorbent assay using a targeted chain oligopeptide, peptide 55.
Al-Sulaiman AM; Vallely PJ; Klapper PE
Clin Vaccine Immunol; 2009 Jun; 16(6):931-4. PubMed ID: 19369475
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a multiplexed herpes simplex virus type-specific immunoglobulin G serology assay to immunoblot, Western blot, and enzyme-linked immunosorbent assays.
Martins TB; Welch RJ; Hill HR; Litwin CM
Clin Vaccine Immunol; 2009 Jan; 16(1):55-60. PubMed ID: 19020107
[TBL] [Abstract][Full Text] [Related]
15. False-negative type-specific glycoprotein G antibody responses in STI clinic patients with recurrent HSV-1 or HSV-2 DNA positive genital herpes, The Netherlands.
van Rooijen MS; Roest W; Hansen G; Kwa D; de Vries HJ
Sex Transm Infect; 2016 Jun; 92(4):257-60. PubMed ID: 26755775
[TBL] [Abstract][Full Text] [Related]
16. Comparison of focus HerpesSelect and Kalon HSV-2 gG2 ELISA serological assays to detect herpes simplex virus type 2 antibodies in a South African population.
Delany-Moretlwe S; Jentsch U; Weiss H; Moyes J; Ashley-Morrow R; Stevens W; Mayaud P
Sex Transm Infect; 2010 Feb; 86(1):46-50. PubMed ID: 19837726
[TBL] [Abstract][Full Text] [Related]
17. Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2.
Schmid DS; Brown DR; Nisenbaum R; Burke RL; Alexander D; Ashley R; Pellett PE; Reeves WC
J Clin Microbiol; 1999 Feb; 37(2):376-9. PubMed ID: 9889222
[TBL] [Abstract][Full Text] [Related]
18. Production of a fragment of glycoprotein G of herpes simplex virus type 2 and evaluation of its diagnostic potential.
Liu T; Liu JF; Yu H; Si GJ; Hu J; Li J
Singapore Med J; 2015 Jun; 56(6):346-52. PubMed ID: 25532518
[TBL] [Abstract][Full Text] [Related]
19. Performance of ELISA and Western blot to detect antibodies against HSV-2 using dried blood spots.
García-Cisneros S; Sánchez-Alemán MÁ; Conde-Glez CJ; Lara-Zaragoza SJ; Herrera-Ortiz A; Plett-Torres T; Olamendi-Portugal M
J Infect Public Health; 2019; 12(2):224-228. PubMed ID: 30389368
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of three multiplex flow immunoassays compared to an enzyme immunoassay for the detection and differentiation of IgG class antibodies to herpes simplex virus types 1 and 2.
Binnicker MJ; Jespersen DJ; Harring JA
Clin Vaccine Immunol; 2010 Feb; 17(2):253-7. PubMed ID: 20007366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]